• Home
  • Site Map
  • Contact Us
  • Graphics Version
  • Printer Version

Amarin

Main Navigation

  • ABOUT US
    • COMPANY PROFILE
    • STRATEGY
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
    • CONTACT US
  • THERAPEUTIC FOCUS
    • CARDIOVASCULAR
    • CNS
      • Huntington's Disease
      • Myasthenia Gravis
      • Parkinson's Disease
      • Epilepsy
  • PRODUCTS
    • PIPELINE
    • AMR101 for Hypertriglyceridemia
    • AMR101 for HD
    • EN101
    • SUBLINGUAL APOMORPHINE
    • NASAL LORAZEPAM
    • AMR103
  • SCIENCE & TECHNOLOGY
    • INTRODUCTION
      • Lipophilic Platform
      • Targeted Lipid Transport Technology Platform
      • Cholinergic Platform
  • PARTNERING
    • PARTNERING
    • BUSINESS DEVELOPMENT
    • STRATEGIC ALLIANCES
  • INVESTOR RELATIONS
    • OVERVIEW
    • STOCK INFORMATION
    • CORPORATE GOVERNANCE
      • AUDIT COMMITTEE
      • REMUNERATION COMMITTEE
      • LEAD INDEPENDENT DIRECTOR
      • CODE OF ETHICS
      • MEMORANDUM AND ARTICLES OF ASSOCIATION
    • PRESENTATIONS
    • PRESS RELEASES
    • EVENTS
    • INVESTOR FAQ
    • REQUEST INVESTOR KIT
    • FINANCIAL REPORTS
    • SEC FILINGS
    • AGM 2008
    • EGM 2008
    • AGM 2007
    • ANALYST COVERAGE
    • EMAIL ALERTS
    • REQUEST INFORMATION

INVESTOR RELATIONS

  • OVERVIEW
  • STOCK INFORMATION
  • CORPORATE GOVERNANCE
  • PRESENTATIONS
  • PRESS RELEASES
  • EVENTS
  • INVESTOR FAQ
  • REQUEST INVESTOR KIT
  • FINANCIAL REPORTS
  • SEC FILINGS
  • AGM 2008
  • EGM 2008
  • AGM 2007
  • ANALYST COVERAGE
  • EMAIL ALERTS
  • REQUEST INFORMATION

Mailing List

Mailing List
Unsubscribe »

INVESTOR RELATIONS

FINANCIAL REPORTS

 

 Type

Description

  2007 REPORTS
PDF Amarin Corporation 2007 Statutory Accounts
PDF Amarin Corporation PLC 2007 Form 20-F

PDF

Unaudited Pro Forma Combined Condensed Consolidated Financial Information giving effect to the acquisition of Ester Neurosciences Limited
PDF Amarin Interim Accounts 2007

 PDF

Amarin Corporation PLC IFRS Conversion Document
  2006 REPORTS
 PDF Amarin Corporation PLC 2006 Annual Report
 PDF Amarin Corporation PLC 2006 Form 20-F
 ZIP Amarin Corporation PLC 2006 Form 20-F

 PDF

Amarin Interim Accounts 2006
  2005 REPORTS
 PDF AIM Schedule 1

 PDF 

IEX Schedule 1
 PDF Appendix_to_Schedule_1

 PDF 

Amarin Corporation PLC - Form 20-F (2005)  
  2004 REPORTS  

 PDF

Amarin Corporation PLC - Form 20-F (2004)

This page was last updated on June 4, 2008.

 


 

  

If you do not have Adobe Acrobat Reader, download it for free.

Registered in England and Wales No. 2353920 - Registered Office: 110 Cannon Street, London, EC4N 6AR

  • Disclaimer
  • Privacy Policy

© 2009 Amarin

Link opens in new windowWeb Design by Webtrade.ie